Skip to content
★ Sign in to follow
JT

Joakim Tedroff

IRLAB Theraoeutics AB
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
7
Company
1
▲ Purchases (2 ops.)
€191k
▼ Sales (1 ops.)
€171k

Latest filing published 12 Nov 2025 for IRLAB Theraoeutics AB, €11k.

Filing timeline

BuySale
Joakim Tedroff

Insider track record

Disclosed buys
2
Disclosed sells
1
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Joakim Tedroff: trading record in brief

Joakim Tedroff is a declared insider of IRLAB Theraoeutics AB, with filings sourced from Finansinspektionen. Between 22 January 2021 and 12 November 2025, the trades on record add up to 7 filings.

Both buying and selling appear: 2 purchases worth €191k, against 1 sale worth €171k. On balance, insiders were net buyers of €20k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2025: 1 purchase and no sales on the market.

The newest entry dates from 12 November 2025: an open-market purchase of €11k, in IRLAB Theraoeutics AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Joakim Tedroff

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesIRLAB Theraoeutics AB
    120,000 SEK7FI-SE
    50,000 shares@ SEK 2.401.6% of flowAktieISIN SE0012675361FI:csv-0c9d4e5565bef9d0820b
    Canonical exit: 10 Feb 2026 (T+90)
  • ●
    Annan ledande befattningshavareExecutivesIRLAB Theraoeutics AB
    2M SEK5FI-SE
    154,930 shares@ SEK 15.6531.2% of flowAktieISIN SE0012675361FI:csv-2317ed4c18a1f76530ca
  • ▲
    Annan ledande befattningshavareExecutivesIRLAB Theraoeutics AB
    2M SEK5FI-SE
    51,430 shares@ SEK 39.6427.2% of flowAktieISIN SE0012675361FI:csv-b21ff7491dd853032cc3
    Canonical exit: 2 Jul 2023 (T+90)
  • ●
    Annan ledande befattningshavareExecutivesIRLAB Theraoeutics AB
    0FI-SE
    84,148 shares0AktieISIN SE0012675361FI:csv-718f8c7073f2b31965d4
  • ▼
    Annan ledande befattningshavareExecutivesIRLAB Theraoeutics AB
    2M SEK5FI-SE
    25,000 shares@ SEK 70.0625.8% of flowAktieISIN SE0012675361FI:csv-1e651ed6e9d590b1f4e1
  • ●
    Annan ledande befattningshavareExecutivesIRLAB Theraoeutics AB
    1M SEK10FI-SE
    25,000 shares@ SEK 42.00100.0% of flowAktieISIN SE0012675361FI:csv-ac3bc2ef5dad1048a9c6

6 of 6 declarations